Neurocrine Bio. (NBIX) PT Lowered to $150 at BMO Capital
BMO Capital analyst Evan David Seigerman ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)